Task: Answer the multiple choice question.
Query: Which drug exhibits a 9.852\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: CCc1ccc(N(C(=O)c2csnn2)C(C(=O)NC(C)(C)C)c2cccnc2)cc1
b: Cc1ccc(-c2nn(CC(=O)NN3CCOCC3)c(=O)c3ccccc23)cc1
Answer: b. Cc1ccc(-c2nn(CC(=O)NN3CCOCC3)c(=O)c3ccccc23)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(-c2nn(CC(=O)NN3CCOCC3)c(=O)c3ccccc23)cc1
Cc1ccc(-c2nn(CC(=O)NN3CCOCC3)c(=O)c3ccccc23)cc1
2-[4-(4-methylphenyl)-1-oxophthalazin-2-yl]-N-morpholin-4-ylacetamide